| Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More | Frank Vinluan | 09/18/20 | National |
| Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early | Sarah de Crescenzo | 08/26/20 | San Francisco |
| Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More | Frank Vinluan | 07/31/20 | National |
| Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test | Sarah de Crescenzo | 07/29/20 | National |
| Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq | Frank Vinluan | 05/22/20 | National |
| Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More | Frank Vinluan | 05/22/20 | National |
| Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More | Frank Vinluan | 05/08/20 | National |
| UCSD, 5 Diagnostic Makers Partner to Ramp COVID-19 Testing Capacity | Sarah de Crescenzo | 03/20/20 | San Diego |
| UC San Diego Health Develops COVID-19 Test, Begins Testing Patients | Sarah de Crescenzo | 03/14/20 | San Diego |
| ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies | Melissa Fassbender | 12/18/19 | Boulder/Denver |
| 6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost | Sarah de Crescenzo | 12/04/19 | New York |
| Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone | Frank Vinluan | 09/06/19 | National |
| Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More | Frank Vinluan | 08/02/19 | National |
| Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal | Jeff Bauter Engel | 07/29/19 | Wisconsin |
| Freenome Snags $160M to Boost Blood Test for Early Cancer Detection | Bernadette Tansey | 07/24/19 | San Francisco |
| Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More | Frank Vinluan | 07/19/19 | National |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up | Jeff Bauter Engel | 04/24/19 | Wisconsin |
| Hatteras Launches New Fund With $94M for Life Science Investments | Frank Vinluan | 04/15/19 | Raleigh Durham |
| Reveal Biosciences Gets Intel’s Backing on “AI-Powered” Pathology | Sarah de Crescenzo | 04/03/19 | San Diego |
| CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M | Ben Fidler | 03/21/19 | Boston |
| San Francisco Biotech: The Next Generation—Photos and Takeaways | Frank Vinluan | 12/26/18 | San Francisco |
| Seer Launches to Develop Liquid Biopsy for Cancer, Brain Disease | Corie Lok | 12/17/18 | San Francisco |
| Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards | Sarah de Crescenzo | 11/30/18 | San Diego |
| WI Watchlist: EatStreet, Exact Sciences, Northwestern Mutual & More | Jeff Bauter Engel | 11/02/18 | Wisconsin |
| Illumina Set to Acquire “Long-Read” DNA Sequencer PacBio for $1.2B | Frank Vinluan | 11/01/18 | San Diego |
| Eyeing NASH, Glympse Raises $22M to Test Disease Detection Nanotech | Frank Vinluan | 10/09/18 | Boston |
| Epic Sciences Raises $52M to Expand Cancer Diagnostic Portfolio | Sarah de Crescenzo | 09/13/18 | San Diego |
| Health Wildcatters Splits Program in Two, Debuts Latest Startup Class | Angela Shah | 09/04/18 | Texas |
| Bio-Techne to Acquire Liquid Biopsy Firm Exosome Diagnostics for $250M | Frank Vinluan | 06/25/18 | Boston |
